Healthcare

MYX

Mayne Pharma Reported Loss Of $134 Million In FY 2018

In FY 2018, the US generic industry faced a tough deflationary period due to customer consolidation and the acceleration of approvals through the US...
SKN

Skin Elements And Affinity To Develop Skincare Products Together

On 8 October 2018, Skin Elements Ltd (ASX: SKN) announced that it has entered into a Memorandum of Understanding (MoU) with Affinity Energy and...
CAJ

CAPITOL HEALTH LIMITED SURGES WITH ACQUISITION OF TWO ADDITIONAL CLINICS IN WA

After the announcement by Capitol Health Limited (ASX: CAJ) in regards to the additional MRI Medicare License process, the company is happy to announce...

ImpediMed Has Finally Completed The Sale Of One Of Its Assets, XiTRON Technologies Inc.

ImpediMed Limited (ASX: IPD) has finally sold one of its asset named XiTRON technologies to Vitrek, LLC. The reason of the sale was that...
ASXMSB

Mesoblast Limited Shares Soar On Completion Of Partnership With China’s Tasly Pharmaceutical

Mesoblast Limited (ASX: MSB) rushed on Australian Securities Exchange after the group completed long standing strategic partnership deal with China’s Tasly Pharmaceutical Group. At...
ASXMVP

Medical Developments International Limited – Green Signal For Penthrox In Saudi Arabia

After Medical Developments International Limited’s (ASX: MVP) exclusive deal for Penthrox in China , MVP has been  granted marketing authorization for the Penthrox medicine...
Healthcare

Clinuvel Pharmaceuticals Ltd advised on Appeal Against NICE Recommendation in England

Clinuvel Pharmaceuticals Ltd (ASX: CUV) and other three consultee organisations representing the erythropoietic protoporphyria  patients (EPP patients) and expert physician requested the appeal hearing...

Cochlear Announces Next Phase In Development Of Totally Implantable Cochlear Implant Technology

Cochlear (ASX: COH) recently announced the next phase in long-term research and development program with the start of a further clinical feasibility study. A...
MEB

Medibio (ASX: MEB) Introduces Corporate Health Product Named “Ilumen”

Medibio Limited (ASX: MEB) from healthcare industry announces to introduce its new product “ilumen” for corporate customers which has a capability to offer biometric...
Cochlear Limited

What’s Happening To Cochlear’s Share Price?

Cochlear Limited (ASX: COH) has been witnessing a strong downtrend since morning. At the time of writing, the stock price stands at A$191.040 per...

Recent News